Quantcast
Last updated on April 24, 2014 at 12:40 EDT

The Stop TB Partnership and The Lilly MDR-TB Partnership, in Conjunction with Innosight, to Convene Multi-Drug Resistant Tuberculosis Innovation Summit

May 17, 2012

A joint Innovation Summit seeks to find solutions for identified barriers to treating tuberculosis.

Boston, MA (PRWEB) May 17, 2012

Leading global public health experts and NGO and business leaders will convene for two days in Lexington, Massachusetts to identify innovative solutions for improving the treatment of multi-drug resistant tuberculosis (MDR-TB), which kills more than 150,000 people each year.

The goal of the Innovation Summit, jointly organized by The Lilly MDR-TB Partnership and the Stop TB Partnership, and facilitated by Innosight, is to find solutions for identified barriers to treating the disease.

MDR-TB is a form of tuberculosis that is resistant to the drugs most commonly used to treat the disease. It afflicts more than 500,000 people worldwide with some 80 percent of cases occurring in India, China, Russia, and South Africa.

Due to drug resistance, MDR-TB must be treated with second-line drugs (SLD). Because of a range of challenges, however, fewer than 20,000 patients are treated each year with quality-assured SLD drugs. The summit will use Innosight´s solutions development process to focus on 14 critical SLD supply chain barriers from the viewpoint of different stakeholders.

In attendance will be more than 35 experts from a variety of organizations dedicated to treating and eradicating MDR-TB, including the World Health Organization, the Centers for Disease Control, Partners in Health, the Global Health Delivery Project at Harvard, USAID, Wal-Mart, IDA Foundation, Eli Lilly and Company, Massachusetts Institute of Technology, and others.

Said Tracy Sims, Vice President, Lilly Foundation, “high-quality second-line drugs for MDR-TB exist, but a variety of barriers cripple the supply chain and result in an unacceptably high number of patients who go untreated. In bringing some of the most talented and committed experts in MDR-TB together at this summit, we believe we can make great progress in developing actionable solutions to break down these barriers, improve access to treatment, and save lives.”

Following the summit, participants will seek to identify methods to test and implement the identified solutions.

About Innosight

Innosight is an innovation consulting firm with offices in Boston, Singapore, and India. It works with companies to develop growth strategies, discover new, high-growth markets, build innovation capabilities, and create disruptive new products, businesses, and services. Its comprehensive, integrated approach converts the quest for innovation and growth into a predictable and reliable process. For more information, visit http://www.innosight.com.

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/5/prweb9519167.htm


Source: prweb